Stealth BioTherapeutics Corp
DelistedCIK 1696396fmd_1YJNKV5NYZYEEKD3S8M72PWERDManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2016 to Dec 31, 2021, 8 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|---|
| Total revenues | – | – | – | 21 | – | – |
| Research and development | 48 | 63 | 53 | 45 | 29 | 27 |
| Total operating expenses | 62 | 80 | 75 | 67 | 49 | 46 |
| Operating income | (62) | (80) | (75) | (46) | (49) | (46) |
| Interest expense | – | 3 | 21 | 7 | 2 | 1 |
| Interest and investment income | 1 | 0 | 0 | 1 | 0 | 0 |
| Other non-operating income (expense) | 1 | (3) | (21) | (26) | (9) | (6) |
| Income before taxes | (61) | (83) | (97) | (72) | (57) | (53) |
| Income tax expense | 0 | 0 | 0 | – | – | – |
| Net income from continuing operations | (61) | (83) | (97) | – | – | – |
| Net income | (61) | (83) | (97) | (72) | (57) | (53) |